Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Dale RC, Tantsis EM, Merheb V, Kumaran R-YA, Sinmaz N, Pathmanandavel K, Ramanathan S, Booth DR, Wienholt LA, Prelog K, et al. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e12. Epub 2014 May 22. PMID: 25340056. Abstract CommentRecommendBookmarkWatch